RRML - Investigation of the Relation Between FAS, FASLG Polymorphisms and Serum Fas, FasL Levels in Patients with Psoriasis
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- August 2018 -
 
Biomarkers in heart failure: f... 20
Involvement of inflammatory cy... 13
Persistent blood eosinophilia ... 13
Biomarkers in Obesity... 12
Increased glycemic variability... 11
Serum hs-CRP, YKL-40 and brain... 10
Romanian Review of Laboratory ... 8
Association between MDR1 gene ... 8
Arylesterase activity of Parao... 8
Postoperative interleukin-8 le... 7

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 26(3)/2018 DOI:10.2478/rrlm-2018-0024
XML
TXT

Research article

Investigation of the Relation Between FAS, FASLG Polymorphisms and Serum Fas, FasL Levels in Patients with Psoriasis

Gülay Gülbol Duran, Mulkiye Kasap, Ramazan Gunesacar, Asena Cigdem Dogramacı, Yasar Gul Denli

Correspondence should be addressed to: Gülay Gülbol Duran

Abstract:

Background: Psoriasis is a multifactorial and inflammatory chronic skin disease indicated with T-cell-mediated keratinocyte hyper-proliferation. Demographic, epidemiological (family, twin), serological, and genetic studies have clearly demonstrated that psoriasis is a polygenic and multifactorial disease. Aim: The objectives of the study are; to determine the prevalence of the polymorphisms of FAS (Fas cell surface receptor gene) -671 A>G (rs:1800682) and FASLG (Fas ligand gene) -844 T>C (rs:763110), to investigate the serum levels of sFas and sFasL, and also to discover any relationship between gene polymorphisms and serum levels in psoriatic patients. Material and Methods: 50 treated and 69 untreated patients, and 140 healthy controls were included in the study. Polymorphisms were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. The serum levels were measured in randomly selected treated (39) and untreated (40) patients, also in 84 healthy controls using micro-ELISA technique. Results: There was no statistical difference between polymorphisms in the patient and control groups. However, sFas and sFasL levels in both treated and untreated patients were higher than that of the controls. Conclusion: The investigated FAS and FASLG polymorphisms were not found to be directly associated with the psoriasis. Elevated sFas and sFasL levels in psoriatic patients showed that these factors may possess a significant role in the pathogenesis of psoriasis.

Keywords: FAS, FASLG, Psoriasis, PCR-RFLP

Received: 5.3.2018
Accepted: 25.6.2018
Published: 25.6.2018

 
  PDF Download full text PDF
(702 KB)
     
 
How to cite
Duran GG, Kasap M, Gunesacar R, Dogramacı AC, Denli YG. Investigation of the Relation Between FAS, FASLG Polymorphisms and Serum Fas, FasL Levels in Patients with Psoriasis. Rev Romana Med Lab. 2018;26(3):325-33. DOI:10.2478/rrlm-2018-0024